Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.

@article{Chang2013SerumLO,
  title={Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.},
  author={Kai-Ping Chang and Chih-Ching Wu and Ku-Hao Fang and Chi-Ying Tsai and Yu-Liang Chang and Shiau-Chin Liu and Huang-Kai Kao},
  journal={Oral oncology},
  year={2013},
  volume={49 8},
  pages={
          802-7
        }
}
  • Kai-Ping Chang, Chih-Ching Wu, +4 authors Huang-Kai Kao
  • Published in Oral oncology 2013
  • Medicine
  • OBJECTIVES The aim of this cohort study was to examine the role of chemokine (C-X-C motif) ligand 9 (CXCL9) on oral cavity squamous cell carcinoma (OSCC). METHODS Sera from 181 OSCC patients, 231 healthy individuals, and 50 OSCC tumor samples were enrolled. CXCL9 expression in tissue samples was analyzed by quantitative real-time PCR and immunohistochemistry. CXCL9 serum concentrations were measured by enzyme-linked immunosorbent assay. Effects of CXCL9 on OSCC cell function were investigated… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 16 CITATIONS

    CXCL9: evidence and contradictions for its role in tumor progression

    VIEW 5 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED

    Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma

    VIEW 1 EXCERPT
    CITES BACKGROUND

    The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma